{
  "meta": {
    "title": "13_Thyroid_Malignancies",
    "url": "https://brainandscalpel.vercel.app/13-thyroid-malignancies-1a65772a.html",
    "scrapedAt": "2025-11-30T12:35:47.028Z"
  },
  "questions": [
    {
      "text": "What is the first investigation you would advise to a patient with a large thyroid swelling?",
      "choices": [
        {
          "id": 1,
          "text": "Ultrasound of the neck"
        },
        {
          "id": 2,
          "text": "FNAC"
        },
        {
          "id": 3,
          "text": "Biochemical function of the thyroid"
        },
        {
          "id": 4,
          "text": "Radioiodine uptake"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Assessing the <strong>biochemical function of the thyroid</strong> i.e. thyroid function test <strong>(TFT)</strong> is the first investigation done in any thyroid condition.</p>\n<p>Assessment of TSH, T3, and T4 is done. However,&nbsp;<strong>TSH</strong> is most helpful in determining the management plan, especially in patients with thyroid nodules who clinically appear to be euthyroid.</p>\n<p>Modalities for evaluation of thyroid swelling include:</p>\n<ul>\n<li>Laboratory evaluation\n<ul>\n<li><strong>TSH</strong></li>\n<li>T3</li>\n<li>T4&nbsp;</li>\n</ul>\n</li>\n<li>Thyroid imaging\n<ul>\n<li><strong>Ultrasound</strong></li>\n<li>Radioisotope scanning</li>\n<li>CT/MRI</li>\n</ul>\n</li>\n<li>Biopsy techniques\n<ul>\n<li><strong>Fine needle aspiration biopsy (FNAB)</strong></li>\n<li>Tru-cut/core-needle biopsy</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8810",
      "difficulty": "medium"
    },
    {
      "text": "A patient presents with a 2.5 cm neck swelling which is firm, non-tender, and moves on swallowing. TSH, T3, and T4 levels are normal. An ultrasound reports the swelling to be cystic and regular with low suspicion for malignancy. What is the next step in the management of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Perform an fine needle aspiration biopsy"
        },
        {
          "id": 2,
          "text": "Perform a Radioiodine uptake test"
        },
        {
          "id": 3,
          "text": "Prepare for resection of nodule"
        },
        {
          "id": 4,
          "text": "Reassure the patient and monitor periodically"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Fine needle aspiration (FNA) biopsy</strong>&nbsp;needs to be performed for further evaluation of the nodule.</p>\n<p>In cases where the FNAC is inconclusive, tru-cut or open biopsy can be done. However, this is rarely required.</p>\n<p>FNAC reporting systems are given as:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Royal College of Pathologists, UK classification</strong></td>\n<td><strong>Bethesda Criteria &nbsp;</strong></td>\n<td><strong>&nbsp;Description</strong></td>\n<td><strong>Usual Management</strong></td>\n</tr>\n<tr>\n<td>\n<p>Thy 1</p>\n<p>Thy 1c</p>\n</td>\n<td>I</td>\n<td>Nondiagnostic or unsatisfactory</td>\n<td>Repeat FNA with image guidance</td>\n</tr>\n<tr>\n<td>&nbsp;Thy 2</td>\n<td>II</td>\n<td>Benign</td>\n<td>Clinical follow-up</td>\n</tr>\n<tr>\n<td rowspan=\"2\">&nbsp;&nbsp;Thy 3</td>\n<td>III</td>\n<td>Atypia of undetermined significance/follicular lesion of undetermined significance</td>\n<td>Repeat FNA or lobectomy</td>\n</tr>\n<tr>\n<td>IV</td>\n<td>Follicular neoplasm or suspicious for follicular neoplasm&nbsp;</td>\n<td>Lobectomy</td>\n</tr>\n<tr>\n<td>&nbsp;Thy 4</td>\n<td>V</td>\n<td>Suspicious for malignancy&nbsp;</td>\n<td>Lobectomy or total thyroidectomy</td>\n</tr>\n<tr>\n<td>&nbsp;Thy 5</td>\n<td>VI</td>\n<td>Malignant&nbsp;</td>\n<td>Total thyroidectomy</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2fd90ad0b05e4d0583451a82a8af1330x1280x2317.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8811",
      "difficulty": "medium"
    },
    {
      "text": "FNAC is useful in all types of thyroid cancers except _____",
      "choices": [
        {
          "id": 1,
          "text": "Medullary"
        },
        {
          "id": 2,
          "text": "Papillary"
        },
        {
          "id": 3,
          "text": "Follicular"
        },
        {
          "id": 4,
          "text": "Anaplastic"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>FNAC</strong> is not useful in the diagnosis of follicular carcinoma of thyroid as it <strong>cannot differentiate </strong>between<strong> benign </strong>and<strong> malignant</strong> follicular lesion.<strong> Trucut biopsy</strong> is used to differentiate between them as follicular thyroid malignancy is defined by<strong> capsular</strong> and <strong>vascular invasion</strong>.&nbsp;</p>\n<p><strong>Limitations </strong>of<strong> FNAC </strong>in thyroid disorders:</p>\n<ul>\n<li>Cannot distinguish between&nbsp;follicular carcinoma and adenoma</li>\n<li>Cannot distinguish between Hurthle cell carcinoma and adenoma</li>\n<li>Not useful in Reidel&rsquo;s thyroiditis</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4684",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following carcinomas of the thyroid arise from the marked cells?<div class='question-desc-html'><ol>\n<li>Papillary</li>\n<li>Follicular</li>\n<li>Hurthle cell</li>\n<li>Anaplastic</li>\n<li>Medullary</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1,4,5"
        },
        {
          "id": 2,
          "text": "2,3"
        },
        {
          "id": 3,
          "text": "2,3,4"
        },
        {
          "id": 4,
          "text": "1,2,3,4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The cell marked in the image is a <strong>follicular</strong> <strong>cell</strong> of the thyroid gland. <strong>Papillary, follicular,</strong> and <strong>anaplastic</strong> thyroid carcinoma are all cancers of the follicular epithelium of the thyroid. <strong>Hurthle cell</strong> carcinoma is a variant of follicular thyroid carcinoma.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8f6bbb6dc72a43058b6d35b301fa9ba5x562x470.JPEG\" alt=\"Explanation Image\"><p>Classification of thyroid neoplasms:</p>\n<ul>\n<li><strong>Benign - </strong>Follicular adenoma</li>\n<li><strong>Malignant</strong>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Origin</strong></td>\n<td><strong>Type</strong></td>\n</tr>\n<tr>\n<td rowspan=\"4\"><strong>Primary</strong></td>\n<td rowspan=\"2\">Follicular epithelium</td>\n<td>Differentiated\n<ul>\n<li>Papillary</li>\n<li>Follicular</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Poorly-differentiated\n<ul>\n<li>Anaplastic</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Parafollicular cells</td>\n<td>Medullary</td>\n</tr>\n<tr>\n<td>Lymphoid cells</td>\n<td>Lymphoma</td>\n</tr>\n<tr>\n<td rowspan=\"2\"><strong>Secondary</strong></td>\n<td>Metastatic</td>\n<td> </td>\n</tr>\n<tr>\n<td>Local infiltration</td>\n<td> </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8d9b25e82c904b83b7c791defa36b868.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8809",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common thyroid malignancy in iodine-deficient regions?",
      "choices": [
        {
          "id": 1,
          "text": "Papillary"
        },
        {
          "id": 2,
          "text": "Anaplastic"
        },
        {
          "id": 3,
          "text": "Follicular"
        },
        {
          "id": 4,
          "text": "Medullary"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Follicular thyroid carcinoma </strong>is the most common<strong>&nbsp;</strong>thyroid malignancy in<strong> iodine-deficient areas.</strong></p>\n<p><strong>Papillary thyroid carcinoma</strong> is the most common thyroid malignancy in <strong>iodine-sufficient areas</strong>, children, and radiation-exposed&nbsp;areas.&nbsp;</p><hr><h3>Related Pearl: Thyroid Malignancy - Most Commons</h3><ul>\n<li>Most common<strong> primary</strong> thyroid malignancy &ndash; Papillary carcinoma</li>\n<li>Most common thyroid malignancy associated with<strong> radiation</strong> - Papillary carcinoma</li>\n<li>Most common malignancy of thyroid associated with<strong> lymphatic spread</strong> &ndash; Papillary carcinoma</li>\n<li>Most common thyroid malignancy associated with <strong>blood and bone metastasis</strong> &ndash; Follicular carcinoma</li>\n<li>Most common thyroid malignancy in <strong>iodine sufficient areas</strong> &ndash; Papillary carcinoma</li>\n<li>Most common thyroid malignancy in <strong>iodine deficient areas</strong> &ndash; Follicular carcinoma</li>\n<li>Most common thyroid malignancy associated with <strong>Multi Nodular Goiter</strong>&nbsp;- Follicular carcinoma</li>\n<li>Thyroid malignancy associated with<strong> amyloid</strong> - Medullary carcinoma</li>\n<li>Thyroid malignancy associated with <strong>MEN 2 syndrome</strong> - Medullary carcinoma</li>\n<li>Most aggressive thyroid malignancy with <strong>worst prognosis</strong> - Anaplastic carcinoma</li>\n<li>Thyroid malignancy with <strong>best prognosis</strong> - Papillary carcinoma</li>\n</ul>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4174",
      "difficulty": "medium"
    },
    {
      "text": "A 58-year-old man with a Thy3 lesion on FNAC was posted for hemithyroidectomy. Histopathology of the frozen section is given below. What is the next step of management?",
      "choices": [
        {
          "id": 1,
          "text": "No further procedure is required"
        },
        {
          "id": 2,
          "text": "Perform a total thyroidectomy"
        },
        {
          "id": 3,
          "text": "Perform RAI ablation"
        },
        {
          "id": 4,
          "text": "Perform central neck dissection"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Capsular</strong><strong>&nbsp;invasion </strong>as seen in the image<strong>&nbsp;</strong>confirms the presence of <strong>follicular carcinoma</strong>. Hence, <strong>total thyroidectomy</strong> is the recommended management.</p>\n<p>As FNAC shows Thy3 lesion which is a follicular neoplasm, the <strong>frozen section</strong> of the excised specimen has to be evaluated. The presence of <strong>capsular</strong> or <strong>vascular invasion </strong>confirms the presence of <strong>follicular carcinoma.</strong></p>\n<p><strong>Surgical management</strong> of differentiated thyroid cancers (DTCs) is as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Extent of cancer</strong></td>\n<td><strong>Surgery done</strong></td>\n</tr>\n<tr>\n<td>\n<p>Low-risk DTC <br />(Fulfilling all 5 of the following conditions)</p>\n<ol>\n<li>&lt; 40 years (better prognosis)</li>\n<li>Unifocal lesion</li>\n<li>Size &lt; 2 cm</li>\n<li>No lymphovascular invasion</li>\n<li>No capsular invasion</li>\n</ol>\n</td>\n<td>Hemithyroidectomy</td>\n</tr>\n<tr>\n<td>\n<p><strong>High-risk DTC without LN involvement </strong><br /><strong>(not fulfilling any of the above 5 conditions)</strong></p>\n</td>\n<td><strong>Total thyroidectomy</strong></td>\n</tr>\n<tr>\n<td>\n<p>High-risk DTC + level VI LN involved</p>\n</td>\n<td>Total thyroidectomy + Central neck dissection</td>\n</tr>\n<tr>\n<td>\n<p>High-risk DTC + other cervical LNs involved</p>\n</td>\n<td>Total thyroidectomy + Modified radical neck dissection</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Follicular thyroid malignancy</h3><p>It is more common in <strong>iodine-deficient areas. </strong>It is associated with p53, PTEN, PAX/PPAR-gamma, RAS, miRNA (miR-197 and miR-346).</p>\n<p>It commonly presents as <strong>solitary thyroid nodules </strong>and the mean age of presentation is <strong>50 years.&nbsp;</strong>It can also occur in long-standing cases of multinodular goitre.</p>\n<p>FNAC&nbsp;is unable to distinguish between benign and malignant follicular lesions as <strong>malignancy</strong> is defined by <strong>capsular</strong> and <strong>vascular invasion. </strong>Hence, <strong>Trucut</strong> biopsy is required to confirm malignancy.</p>\n<p>Histological findings:</p>\n<ul>\n<li>Encapsulated</li>\n<li>Uniform microfollicles&nbsp;or sheets of cells devoid of colloid</li>\n<li>Capsular and vascular invasion indicates malignancy</li>\n<li>Tumour thrombus within middle thyroid/ jugular veins may be seen at the time of surgery</li>\n</ul>\n<p><strong>Vascular</strong> (hematogenous) dissemination is common, with metastases to bone, lungs, liver, and elsewhere. The prognosis depends largely on the extent of invasion and stage at presentation.</p>\n<p>Serum <strong>thyroglobulin</strong> levels are used for monitoring tumour recurrence, as they are undetectable after complete treatment.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c3aedbd5554f460b997db5f91dbff7be.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4685",
      "difficulty": "easy"
    },
    {
      "text": "All of the following statements are true about follicular thyroid carcinoma except:",
      "choices": [
        {
          "id": 1,
          "text": "Thyroglobulin levels can be used to monitor patients for recurrence"
        },
        {
          "id": 2,
          "text": "Hematogenous spread is more common than lymphatic spread"
        },
        {
          "id": 3,
          "text": "Osteoblastic bone metastasis is seen"
        },
        {
          "id": 4,
          "text": "Mortality rate is twice that of papillary thyroid carcinoma"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Osteolytic bone metastasis</strong> is seen in follicular thyroid carcinoma and not osteoblastic lesions.</p>\n<p>Thyroglobulin trends may be used to monitor patients with differentiated thyroid cancer for a recurrence. Following <strong>total</strong> <strong>thyroidectomy</strong>, <strong>thyroglobulin</strong> levels must be <strong>undetectable</strong>.</p>\n<p>All thyroid carcinoma, except medullary thyroid carcinoma, have osteolytic bony metastasis. <strong>Medullary</strong> thyroid cancer has <strong>osteoblastic</strong> bony metastasis.</p>\n<p>Differentiated thyroid carcinomas (papillary &amp; follicular):</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Papillary carcinoma</strong></td>\n<td><strong>Follicular carcinoma</strong></td>\n</tr>\n<tr>\n<td>Incidence</td>\n<td>Most common</td>\n<td>2nd most common</td>\n</tr>\n<tr>\n<td>Past history</td>\n<td>Radiation exposure</td>\n<td>Long-standing goitre</td>\n</tr>\n<tr>\n<td>Risk factor</td>\n<td><strong>Iodine-sufficient</strong> areas</td>\n<td><strong>Iodine-deficient</strong> areas</td>\n</tr>\n<tr>\n<td>Metastatic spread via</td>\n<td><strong>Lymphatics</strong> &gt; Hematogenous</td>\n<td><strong>Hematogenous</strong> &gt; Lymphatics</td>\n</tr>\n<tr>\n<td>Diagnosis by FNAC</td>\n<td>Useful</td>\n<td>Not useful</td>\n</tr>\n<tr>\n<td>Prognosis</td>\n<td>More favourable</td>\n<td>Less favourable</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Follicular thyroid malignancy</h3><p>It is more common in <strong>iodine-deficient areas. </strong>It is associated with p53, PTEN, PAX/PPAR-gamma, RAS, miRNA (miR-197 and miR-346).</p>\n<p>It commonly presents as <strong>solitary thyroid nodules </strong>and the mean age of presentation is <strong>50 years.&nbsp;</strong>It can also occur in long-standing cases of multinodular goitre.</p>\n<p>FNAC&nbsp;is unable to distinguish between benign and malignant follicular lesions as <strong>malignancy</strong> is defined by <strong>capsular</strong> and <strong>vascular invasion. </strong>Hence, <strong>Trucut</strong> biopsy is required to confirm malignancy.</p>\n<p>Histological findings:</p>\n<ul>\n<li>Encapsulated</li>\n<li>Uniform microfollicles&nbsp;or sheets of cells devoid of colloid</li>\n<li>Capsular and vascular invasion indicates malignancy</li>\n<li>Tumour thrombus within middle thyroid/ jugular veins may be seen at the time of surgery</li>\n</ul>\n<p><strong>Vascular</strong> (hematogenous) dissemination is common, with metastases to bone, lungs, liver, and elsewhere. The prognosis depends largely on the extent of invasion and stage at presentation.</p>\n<p>Serum <strong>thyroglobulin</strong> levels are used for monitoring tumour recurrence, as they are undetectable after complete treatment.</p><hr><h3>Related Pearl: Types of metastasis(osteoblastic or osteolytic) and their primary:</h3><p><span><strong>Predominantly osteoblastic:</strong></span></p>\n<ul>\n<li><span>Prostate cancer</span></li>\n<li><span>Osteosarcoma&nbsp;</span></li>\n<li><span>Medullary carcinoma thyroid</span></li>\n</ul>\n<p><span><strong>Mixed osteoblastic and osteolytic:</strong></span></p>\n<ul>\n<li><span>Breast cancer(preponderance toward osteolytic)</span></li>\n<li><span>Lymphoma</span></li>\n<li><span>Urothelial carcinoma&nbsp;</span></li>\n<li><span>Lung cancer</span></li>\n</ul>\n<p><span><strong>Predominantly osteolytic:</strong></span></p>\n<ul>\n<li><span>Renal cell carcinoma</span></li>\n<li><span>Multiple myeloma&nbsp;</span></li>\n<li><span>Thyroid carcinoma(except medullary carcinoma thyroid)</span></li>\n<li><span>Gastrointestinal tract carcinoma</span></li>\n<li><span>Malignant melanoma</span></li>\n</ul><hr><h3>Related Pearl: Papillary thyroid carcinoma</h3><p>Papillary carcinoma is the <strong>most common</strong> thyroid carcinoma. It is most common in <strong>iodine sufficient areas</strong>, <strong>children</strong> and in those exposed to <strong>ionizing</strong>&nbsp;<strong>radiation.</strong>&nbsp;</p>\n<p>The mean age of presentation is<strong> 3rd-4th</strong> decade and is more common in <strong>women</strong> than men (2:1).&nbsp;<strong>Dysphagia</strong>, <strong>dysphonia</strong> and <strong>dyspnea</strong> are associated with local invasion.</p>\n<p>It usually presents as a&nbsp;<strong>cold nodule </strong>on the scan. Histological findings include:</p>\n<ul>\n<li>Branching&nbsp;papillae&nbsp;</li>\n<li>Follicles with the fibrovascular stalk</li>\n<li><strong>Psammoma bodies</strong></li>\n<li>Nuclear changes-&nbsp;\n<ul>\n<li>Optically clear -&nbsp;Ground glass&nbsp;or&nbsp;<strong>Orphan Annie eye nuclei</strong></li>\n<li>Pseudo-inclusions</li>\n<li>Nuclear grooves.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Lymph</strong> node metastasis is common.&nbsp;<strong>Lateral aberrant thyroid</strong> denotes a cervical lymph node invaded by papillary carcinoma. The most common sites of metastasis : <strong>lung</strong> &gt; liver &gt; bone &gt; brain.</p>\n<p>It has an <strong>excellent prognosis</strong>, with a 10-year survival rate in excess of 95%.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8816",
      "difficulty": "medium"
    },
    {
      "text": "A patient with a unilateral thyroid mass was diagnosed to have follicular thyroid carcinoma with involvement of level VI cervical lymph nodes. What is the appropriate management?",
      "choices": [
        {
          "id": 1,
          "text": "Hemithyroidectomy with radioactive iodine ablation"
        },
        {
          "id": 2,
          "text": "Hemithyroidectomy with lateral neck dissection"
        },
        {
          "id": 3,
          "text": "Total thyroidectomy  with modified radical neck dissection"
        },
        {
          "id": 4,
          "text": "Total thyroidectomy with central neck dissection"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Patients with follicular thyroid carcinoma with level VI lymph node involvement are managed by <strong>total thyroidectomy</strong> with<strong> central neck dissection</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/508b7824cf3944adae5daf9bd4e95ba4x600x666.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/428682db32154b1c89456a7364131161x1280x1826.JPEG\" alt=\"Explanation Image\"><p>Surgical management of differentiated thyroid cancers (DTCs) is as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Extent of cancer</strong></td>\n<td><strong>Surgery done</strong></td>\n</tr>\n<tr>\n<td>\n<p>Low-risk DTC <br />(Fulfilling all 5 of the following conditions)</p>\n<ol>\n<li>&lt; 40 years (better prognosis)</li>\n<li>Unifocal lesion</li>\n<li>Size &lt; 2 cm</li>\n<li>No lymphovascular invasion</li>\n<li>No capsular invasion</li>\n</ol>\n</td>\n<td>Hemithyroidectomy</td>\n</tr>\n<tr>\n<td>\n<p>High- risk DTC without LN involvement <br />(not fulfilling all of the above 5 conditions)</p>\n</td>\n<td>Total thyroidectomy</td>\n</tr>\n<tr>\n<td>\n<p><strong>High-risk DTC + level VI LN involved</strong></p>\n</td>\n<td><strong>Total thyroidectomy + Central neck dissection</strong></td>\n</tr>\n<tr>\n<td>\n<p>High-risk DTC + other LNs involved</p>\n</td>\n<td>Total thyroidectomy + Modified radical neck dissection</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Types of Neck Dissections</h3><table>\n<tbody>\n<tr>\n<td><strong>Dissection</strong></td>\n<td><strong>LN removed</strong></td>\n<td><strong>Other structures removed/preserved</strong></td>\n</tr>\n<tr>\n<td><strong>RND</strong></td>\n<td>l-V</td>\n<td>CNXI, IJV, SCM removed</td>\n</tr>\n<tr>\n<td><strong>MRND l</strong></td>\n<td>l-V</td>\n<td>CNXI preserved</td>\n</tr>\n<tr>\n<td><strong>MRND ll</strong></td>\n<td>l-V</td>\n<td>CNXI, IJV preserved</td>\n</tr>\n<tr>\n<td><strong>MRND lll</strong></td>\n<td>l-V</td>\n<td>CNXI, IJV, SCM preserved</td>\n</tr>\n<tr>\n<td><strong>END</strong></td>\n<td>l-V</td>\n<td>CNXI, IJV, SCM removed+ one/more LN groups +/- non-lymphatic structures</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>SND</strong></td>\n<td><strong>LN removed</strong></td>\n<td><strong>Primary site of cancer</strong></td>\n</tr>\n<tr>\n<td><strong>Supra-omohyoid</strong></td>\n<td>l-lll</td>\n<td>Oral cavity</td>\n</tr>\n<tr>\n<td><strong>Extended supra-omohyoid</strong></td>\n<td>l-lV</td>\n<td>Oral cavity and oropharynx</td>\n</tr>\n<tr>\n<td><strong>Postero-lateral</strong></td>\n<td>\n<p>ll-V</p>\n</td>\n<td>\n<p>Skin over posterior scalp and upper neck</p>\n</td>\n</tr>\n<tr>\n<td><strong>Lateral</strong></td>\n<td>ll-lV</td>\n<td>\n<p>Oropharynx, hypopharynx,&nbsp;larynx</p>\n</td>\n</tr>\n<tr>\n<td><strong>Anterior(Central)</strong></td>\n<td>Vl</td>\n<td>Thyroid/midline structures</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>RND- Radical Neck Dissection; MRND- Modified Radical Neck Dissection; END- Extended&nbsp;Neck Dissection; SND- Selective&nbsp;Neck Dissection</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8817",
      "difficulty": "medium"
    },
    {
      "text": "A patient presented with a thyroid nodule. The USG showed an irregular hypoechoic mass with microcalcifications. Lymph nodes were not involved. FNAC showed a follicular neoplasm with predominantly Hurthle cells. Intra-op frozen section confirms capsular invasion. What is the most appropriate management?",
      "choices": [
        {
          "id": 1,
          "text": "Total thyroidectomy central neck dissection"
        },
        {
          "id": 2,
          "text": "Total thyroidectomy"
        },
        {
          "id": 3,
          "text": "Hemithyroidectomy"
        },
        {
          "id": 4,
          "text": "Hemithyroidectomy with radioiodine ablation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>Hurthle cell follicular carcinoma</strong>. The most appropriate management is<strong> total thyroidectomy</strong>&nbsp;with prophylactic<strong> central neck dissection.&nbsp;</strong>Hurthle cell carcinoma is a variant of follicular thyroid carcinoma.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d247de175eeb41ba8a811455b533118dx1280x1168.JPEG\" alt=\"Explanation Image\"><p>As compared to follicular thyroid cancer, it has a <strong>poorer prognosis</strong> as it is more likely to <strong>metastasize</strong>. It is often bilateral and multifocal. The histological&nbsp;picture consists of <strong>predominantly oxyphil</strong> (Hurthle, Askanazy) cells containing abundant mitochondria. It cannot be diagnosed solely by FNAC as these cancers are characterized by vascular &amp; capsular invasion.</p>\n<p>Surgical management of Hurthle cell carcinoma:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Extent of cancer</strong></td>\n<td><strong>Surgery done</strong></td>\n</tr>\n<tr>\n<td>Unilateral Hurthle cell adenoma</td>\n<td>Hemithyroidectomy</td>\n</tr>\n<tr>\n<td>Bilateral involvement without level VI LNs involvement</td>\n<td>Total thyroidectomy + &nbsp;<strong>Central neck dissection (prophylactic)</strong></td>\n</tr>\n<tr>\n<td>Hurthle cell carcinoma with level VI LNs involved</td>\n<td>Total thyroidectomy +&nbsp; Central neck dissection (therapeutic)</td>\n</tr>\n<tr>\n<td>Hurthle cell carcinoma with other LNs involved</td>\n<td>Total thyroidectomy + Modified radical neck dissection&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8818",
      "difficulty": "medium"
    },
    {
      "text": "A 32-year-old woman came to the surgeon with a thyroid swelling that had developed a year ago. On examination, the swelling was 3 cm in size, firm and immobile. Further, lymphadenopathy was present. A biopsy of the swelling is given below. Which of the following is incorrect regarding management and post-op care in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Calcium supplementation is given post-operatively"
        },
        {
          "id": 2,
          "text": "Prophylactic neck dissection is done"
        },
        {
          "id": 3,
          "text": "Thyroxine is withheld after the surgery"
        },
        {
          "id": 4,
          "text": "Hemithyroidectomy is performed"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given histological image depicts papillary formation with a fibrovascular stalk, characteristic <strong>orphan annie eye nuclei </strong>and <strong>psammoma bodies</strong>, diagnostic of <strong>papillary carcinoma</strong> of the thyroid.<br /><strong>Total thyroidectomy</strong> with <strong>central neck dissection</strong> would be the appropriate management in this condition, because there is <strong>lymphadenopathy, </strong>although the tumour size is less than 4 cm.</p>\n<p>Surgical management of differentiated thyroid cancers (DTCs) is as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Extent of cancer</strong></td>\n<td><strong>Surgery done</strong></td>\n</tr>\n<tr>\n<td>\n<p>Low-risk DTC <br />(Fulfilling all 5 of the following conditions)</p>\n<ol>\n<li>&lt; 40 years (better prognosis)</li>\n<li>Unifocal lesion</li>\n<li><strong>Size ~ 1-4 cm</strong></li>\n<li>No lymphovascular invasion</li>\n<li>No capsular invasion</li>\n</ol>\n</td>\n<td>Hemithyroidectomy</td>\n</tr>\n<tr>\n<td>\n<p><strong>High-risk DTC without LN involvement / </strong><strong>not fulfilling any of the above 5 conditions</strong></p>\n</td>\n<td><strong>Total thyroidectomy</strong></td>\n</tr>\n<tr>\n<td>\n<p>High-risk DTC + level VI LN involved</p>\n</td>\n<td>Total thyroidectomy + Central neck dissection</td>\n</tr>\n<tr>\n<td>\n<p>High-risk DTC + other LNs involved</p>\n</td>\n<td>Total thyroidectomy + Modified radical neck dissection</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div class=\"page\" title=\"Page 2\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p> </p>\n<p>The other options:<br />Option 1: Post thyroidectomy, calcium supplementation is given to all patients to prevent hypocalcemia.<br />Option 2: Prophylactic neck dissection is done for papillary carcinoma thyroid<br />Option 3: Thyroid hormone replacement is not given to patients who are to receive radioactive iodine therapy within 2 to 3 weeks of surgery. The absence of thyroid hormones raises the TSH, which stimulates the radioactive iodine uptake.</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/87b3c0031f2141df88d7aacc4b980d21x1279x1159.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Papillary thyroid carcinoma</h3><p>Papillary carcinoma is the <strong>most common</strong> thyroid carcinoma. It is most common in <strong>iodine sufficient areas</strong>, <strong>children</strong> and in those exposed to <strong>ionizing</strong>&nbsp;<strong>radiation.</strong>&nbsp;</p>\n<p>The mean age of presentation is<strong> 3rd-4th</strong> decade and is more common in <strong>women</strong> than men (2:1).&nbsp;<strong>Dysphagia</strong>, <strong>dysphonia</strong> and <strong>dyspnea</strong> are associated with local invasion.</p>\n<p>It usually presents as a&nbsp;<strong>cold nodule </strong>on the scan. Histological findings include:</p>\n<ul>\n<li>Branching&nbsp;papillae&nbsp;</li>\n<li>Follicles with the fibrovascular stalk</li>\n<li><strong>Psammoma bodies</strong></li>\n<li>Nuclear changes-&nbsp;\n<ul>\n<li>Optically clear -&nbsp;Ground glass&nbsp;or&nbsp;<strong>Orphan Annie eye nuclei</strong></li>\n<li>Pseudo-inclusions</li>\n<li>Nuclear grooves.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Lymph</strong> node metastasis is common.&nbsp;<strong>Lateral aberrant thyroid</strong> denotes a cervical lymph node invaded by papillary carcinoma. The most common sites of metastasis : <strong>lung</strong> &gt; liver &gt; bone &gt; brain.</p>\n<p>It has an <strong>excellent prognosis</strong>, with a 10-year survival rate in excess of 95%.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/6cad839cfa8e4cedbbb7ba264d3f93d1.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8814",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following describes lateral aberrant thyroid?",
      "choices": [
        {
          "id": 1,
          "text": "Defective development of the fourth pharyngeal pouch"
        },
        {
          "id": 2,
          "text": "Metastatic thyroid cancer in lymph nodes"
        },
        {
          "id": 3,
          "text": "Hyperplastic growth of thyroid tissue"
        },
        {
          "id": 4,
          "text": "Cystic swelling of the thyroglossal duct"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Lateral aberrant thyroid</strong> almost always represents <strong>metastatic thyroid cancer </strong>in <strong>lymph nodes</strong>.</p>\n<p>Thyroid tissue situated lateral to the carotid sheath and jugular vein found along the course of the thyroglossal duct was previously termed lateral aberrant thyroid. It is associated with <strong>papillary thyroid cancer</strong> in the ipsilateral thyroid lobe.</p>\n<p>The image given below shows the lateral aberrant thyroid.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2f7f55e4cbb64e69bf731a6eaf368107x720x503.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Papillary thyroid carcinoma</h3><p>Papillary carcinoma is the <strong>most common</strong> thyroid carcinoma. It is most common in <strong>iodine sufficient areas</strong>, <strong>children</strong> and in those exposed to <strong>ionizing</strong>&nbsp;<strong>radiation.</strong>&nbsp;</p>\n<p>The mean age of presentation is<strong> 3rd-4th</strong> decade and is more common in <strong>women</strong> than men (2:1).&nbsp;<strong>Dysphagia</strong>, <strong>dysphonia</strong> and <strong>dyspnea</strong> are associated with local invasion.</p>\n<p>It usually presents as a&nbsp;<strong>cold nodule </strong>on the scan. Histological findings include:</p>\n<ul>\n<li>Branching&nbsp;papillae&nbsp;</li>\n<li>Follicles with the fibrovascular stalk</li>\n<li><strong>Psammoma bodies</strong></li>\n<li>Nuclear changes-&nbsp;\n<ul>\n<li>Optically clear -&nbsp;Ground glass&nbsp;or&nbsp;<strong>Orphan Annie eye nuclei</strong></li>\n<li>Pseudo-inclusions</li>\n<li>Nuclear grooves.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Lymph</strong> node metastasis is common.&nbsp;<strong>Lateral aberrant thyroid</strong> denotes a cervical lymph node invaded by papillary carcinoma. The most common sites of metastasis : <strong>lung</strong> &gt; liver &gt; bone &gt; brain.</p>\n<p>It has an <strong>excellent prognosis</strong>, with a 10-year survival rate in excess of 95%.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0291",
      "difficulty": "medium"
    },
    {
      "text": "Which type of thyroid cancer has the best prognosis?",
      "choices": [
        {
          "id": 1,
          "text": "Medullary carcinoma"
        },
        {
          "id": 2,
          "text": "Follicular carcinoma"
        },
        {
          "id": 3,
          "text": "Papillary carcinoma"
        },
        {
          "id": 4,
          "text": "Hurthle cell carcinoma"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Patients with papillary thyroid carcinoma have an <strong>excellent prognosis</strong> with a &gt;95% 10-year survival rate.</p><hr><h3>Related Pearl: Thyroid Malignancy - Most Commons</h3><ul>\n<li>Most common<strong> primary</strong> thyroid malignancy &ndash; Papillary carcinoma</li>\n<li>Most common thyroid malignancy associated with<strong> radiation</strong> - Papillary carcinoma</li>\n<li>Most common malignancy of thyroid associated with<strong> lymphatic spread</strong> &ndash; Papillary carcinoma</li>\n<li>Most common thyroid malignancy associated with <strong>blood and bone metastasis</strong> &ndash; Follicular carcinoma</li>\n<li>Most common thyroid malignancy in <strong>iodine sufficient areas</strong> &ndash; Papillary carcinoma</li>\n<li>Most common thyroid malignancy in <strong>iodine deficient areas</strong> &ndash; Follicular carcinoma</li>\n<li>Most common thyroid malignancy associated with <strong>Multi Nodular Goiter</strong>&nbsp;- Follicular carcinoma</li>\n<li>Thyroid malignancy associated with<strong> amyloid</strong> - Medullary carcinoma</li>\n<li>Thyroid malignancy associated with <strong>MEN 2 syndrome</strong> - Medullary carcinoma</li>\n<li>Most aggressive thyroid malignancy with <strong>worst prognosis</strong> - Anaplastic carcinoma</li>\n<li>Thyroid malignancy with <strong>best prognosis</strong> - Papillary carcinoma</li>\n</ul>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4671",
      "difficulty": "easy"
    },
    {
      "text": "A 45-year-old man came to the surgery OPD with a midline neck swelling. He does not have any other complaints. The patient had received chemoradiation for Hodgkin’s lymphoma nearly 20 years ago. On palpation, the mass is about 3 cm in size, non-tender, hard, fixed, and seems to arise from the right lobe of the thyroid. TSH levels were raised. A radioiodine uptake study showed cold nodule. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Anaplastic thyroid cancer"
        },
        {
          "id": 2,
          "text": "Thyroid lymphoma"
        },
        {
          "id": 3,
          "text": "Papillary thyroid cancer"
        },
        {
          "id": 4,
          "text": "Medullary thyroid cancer"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The history of radiation therapy to the head and neck for Hodkin's lymphoma and a cold nodule on radioiodine uptake scan are suggestive of&nbsp;<strong>papillary thyroid cancer.</strong></p>\n<p><strong>Radiation exposure</strong>&nbsp;is an identifiable aetiological factor in the development of differentiated thyroid cancer (follicular and papillary thyroid cancer). The most important factor, however, is <strong>irradiation of the thyroid before 5 years of age. </strong></p>\n<p><strong>Thyroid lymphomas</strong>&nbsp;are non-Hodgkin&rsquo;s B-cell lymphomas. They present with&nbsp;B-symptoms like fever, night sweats, and weight loss in addition to neck swelling. Thus, thyroid lymphoma is an unlikely diagnosis. Thyroid lymphomas&nbsp;often develop in the setting of lymphocytic infiltration.&nbsp;</p><p>In the town of Gomel, Ukraine, the incidence of childhood thyroid cancer rose from &lt;1 per million to 96 per million following the Chernobyl nuclear disaster.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8813",
      "difficulty": "medium"
    },
    {
      "text": "A 45-year-old patient presents with diffuse enlargement of the thyroid gland. Laboratory studies reveal low T3, T4, high TSH and the presence of anti-TPO antibodies. FNAC from the gland shows enlarged cells with abundant eosinophilic cytoplasm. Which of the following malignancies is commonly associated with this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Follicular carcinoma"
        },
        {
          "id": 2,
          "text": "Anaplastic carcinoma"
        },
        {
          "id": 3,
          "text": "Thyroid lymphoma"
        },
        {
          "id": 4,
          "text": "Hurthle cell carcinoma"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical case scenario is suggestive of <strong>Hashimoto's thyroiditis</strong>. <strong>Thyroid lymphoma</strong> or malignant lymphoma is associated with long-standing Hashimoto’s thyroiditis.</p>\n<p>Thyroid lymphomas are usually <strong>non-Hodgkin’s</strong> lymphomas, often associated with long-standing <strong>Hashimoto’s thyroiditis</strong> (autoimmune lymphocytic thyroiditis).</p>\n<p>The clinical features include: <strong>B - symptoms</strong> i.e. fever, night sweats, and weight loss</p>\n<p>As FNAC cannot characterize lymphoma, Tru-Cut biopsy is preferred. Chemotherapy and radiation therapy are often sufficient. Total thyroidectomy is indicated only in residual/recurrent disease.</p>\n<p>A chemotherapy regimen <strong>(RCHOP)</strong> is the first line of management.<br /><strong>R</strong> - Rituximab<br /><strong>C</strong> - Cyclophosphamide<br /><strong>H</strong> - Hydroxydaunorubicin (Adriamycin)<br /><strong>O</strong> - Oncovin (Vincristine)<br /><strong>P</strong> - Prednisolone</p><p>The prevalence of thyroid lymphoma is <strong>80 times higher</strong> in people with Hashimoto’s thyroiditis as compared to the normal population.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8824",
      "difficulty": "hard"
    },
    {
      "text": "A 72-year-old woman has a history of papillary thyroid carcinoma left untreated for 2 years. She complains that the rapid enlargement in her neck swelling over the last month has made it difficult for her to swallow and talk. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Local invasion of the surrounding structures"
        },
        {
          "id": 2,
          "text": "Progression to Hurthle cell carcinoma"
        },
        {
          "id": 3,
          "text": "Conversion to follicular thyroid cancer"
        },
        {
          "id": 4,
          "text": "Anaplastic thyroid cancer"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>An <strong>elderly woman</strong> with <strong>rapidly enlarging</strong> neck mass and <strong>dysphagia</strong> in the setting of an <strong>untreated papillary carcinoma</strong> suggests a diagnosis of <strong>anaplastic thyroid cancer</strong>.</p>\n<p>Anaplastic thyroid cancer, a <strong>poorly differentiated</strong>&nbsp;thyroid carcinoma, is the <strong>most aggressive cancer</strong> and has the <strong>worst prognosis</strong>&nbsp;of all thyroid malignancies.&nbsp;</p>\n<p>It usually occurs in&nbsp;<strong>elderly females.</strong> The typical manifestation is an with <strong>rapidly enlarging</strong> neck mass, dysphagia, and cervical tenderness. Patients usually have a history of untreated <strong>differentiated thyroid carcinoma (DTC).&nbsp;</strong>Local invasion to the recurrent laryngeal nerve <strong>(RLN)</strong> causes hoarseness. It may also cause tracheal obstruction.&nbsp;<strong>Distant metastasis</strong> is more common in the&nbsp;<strong>lungs</strong> via the hematogenous route.</p>\n<p>Diagnosis is made by <strong>FNAC.</strong> However, trucut/open biopsy is frequently used to confirm the diagnosis in cases of doubt.<strong><br /></strong></p>\n<p>Management:</p>\n<ul>\n<li>If <strong>metastasis is absent:</strong> Total thyroidectomy + LN dissection</li>\n<li>If <strong>metastasis is present:</strong> Palliative care with chemotherapy and radiotherapy</li>\n<li>If <strong>tracheal obstruction:</strong> Isthmectomy to relieve obstruction</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8823",
      "difficulty": "medium"
    },
    {
      "text": "A 34-year-old woman was brought in a dehydrated state and complains of loose stools. On examination, a tender neck swelling was found which was found to be present for 1 year. Histopathology of the swelling shows the following finding. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Medullary thyroid carcinoma"
        },
        {
          "id": 2,
          "text": "Systemic amyloidosis"
        },
        {
          "id": 3,
          "text": "Thyroid lymphoma"
        },
        {
          "id": 4,
          "text": "Papillary thyroid carcinoma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario<strong>&nbsp;</strong>is suggestive of <strong>medullary thyroid carcinoma </strong>(MTC).&nbsp;Histopathology shows the presence of amyloid deposits that are derived from the altered calcitonin molecules.</p>\n<p>Medullary thyroid carcinoma is a tumor of <strong>parafollicular or C cells</strong>&nbsp;of the thyroid gland. They are derived from the neural crest cells of the&nbsp;<strong>ultimobranchial bodies</strong>.&nbsp;</p>\n<p>Most of the MTCs occur sporadically. However, around a quarter of the cancers are associated with familial MTC, MEN2A, and MEN2B.</p>\n<p>Patients with sporadic MTC present at an older age, whereas patients with familial MTC usually present at a younger age.&nbsp;Features of MTC include:</p>\n<ul>\n<li>Painful neck mass with cervical lymphadenopathy</li>\n<li>Dysphagia, dysphonia or dyspnea if locally invaded</li>\n<li><strong>Diarrhoea</strong>&nbsp;due to increased intestinal motility by serotonin</li>\n<li><strong>Cushingoid habitus</strong>&nbsp;due to ectopic ACTH production</li>\n<li>Metastasis is&nbsp;<strong>blood-borne</strong></li>\n<li>Microscopically, they consist of sheets of neoplastic cells separated by collagen and&nbsp;<strong>amyloid stroma</strong></li>\n</ul>\n<p>It is diagnosed by careful family history, physical examination,&nbsp;<strong>raised calcitonin, CEA levels</strong>, and fine-needle aspiration biopsy of the mass.</p>\n<p><strong>Total thyroidectomy</strong>&nbsp;with&nbsp;<strong>central neck node dissection</strong>&nbsp;is the treatment of choice in MTC patients. External beam radiotherapy can be used in patients with unresectable tumors. Targeted therapy can be considered using vandetanib, sorafenib, sunitinib, and cabozantinib.</p>\n<p><strong>Prophylactic total thyroidectomy</strong>&nbsp;should be considered within&nbsp;<strong>5years</strong>&nbsp;of age in<strong>&nbsp;MEN2A</strong>&nbsp;mutation and within&nbsp;<strong>1year</strong>&nbsp;of age in&nbsp;<strong>MEN2B</strong>&nbsp;mutation.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/39a84c606e19450086350fdba90d72c7.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8819",
      "difficulty": "easy"
    },
    {
      "text": "Choose the substances secreted by medullary thyroid carcinoma:<div class='question-desc-html'><ol>\n<li>Calcitonin</li>\n<li>Carcinoembryonic antigen</li>\n<li>Serotonin</li>\n<li>Thyroglobulin</li>\n<li>Histaminidase</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1,2"
        },
        {
          "id": 2,
          "text": "2,3,4"
        },
        {
          "id": 3,
          "text": "1,3,4,5"
        },
        {
          "id": 4,
          "text": "1,2,3,5"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Medullary thyroid tumors secrete calcitonin, serotonin, histaminadases, and CEA (carcinoembryonic antigen).</p><hr><h3>Related Pearl: Secretion of medullary thyroid tumors</h3><p>Medullary thyroid tumor secrete the following:</p>\n<ul>\n<li><strong>Calcitonin </strong></li>\n<li><strong>Carcinoembryonic antigen (CEA)</strong></li>\n<li>Calcitonin gene&ndash;related peptide</li>\n<li>Histaminadases</li>\n<li>Prostaglandins E 2 and F 2 &alpha;</li>\n<li>Serotonin</li>\n</ul>\n<p>Calcitonin and serotonins are responsible for diarrhea in MTC.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4698",
      "difficulty": "medium"
    },
    {
      "text": "A patient with medullary thyroid carcinoma is posted for surgery. He is nearly 6.5 ft tall, with a slender build and elongated digits. What is the screening test that should be done pre-operatively?",
      "choices": [
        {
          "id": 1,
          "text": "MRI-Brain"
        },
        {
          "id": 2,
          "text": "Serum calcium"
        },
        {
          "id": 3,
          "text": "Urinary catecholamines"
        },
        {
          "id": 4,
          "text": "IGF-1 assay"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This patient with <strong>medullary thyroid carcinoma</strong> and features of <strong>marfanoid </strong>habitus (very tall patient with long, slender fingers and toes) is suggestive of <strong>MEN 2B</strong> syndrome. Such patients are to be <strong>screened</strong> for <strong>pheochromocytoma</strong> by measuring <strong>urinary catecholamines.</strong></p>\n<p>Pheochromocytoma, if present, should be treated first, and then MTC is to be treated next.</p>\n<p>A thyroid swelling with elevated calcitonin indicates a medullary thyroid carcinoma (MTC). MTC can either be <strong>sporadic</strong> (80%) or <strong>familial</strong> (RET gene mutation). In case of <strong>familial</strong> medullary thyroid carcinoma, <strong>stimulation</strong> with <strong>pentagastrin</strong> increases the release of calcitonin. This can be used for the screening of medullary thyroid carcinoma.</p>\n<p>MTC can be inherited as a part of <strong>autosomal dominant</strong> (AD) syndromes such as:</p>\n<ul>\n<li>Familial MTC</li>\n<li>MEN 2A</li>\n<li>MEN 2B</li>\n</ul>\n<p><strong>Prophylactic total thyroidectomy</strong> should be considered within <strong>5years</strong> of age in<strong> MEN2A</strong> mutation and within <strong>1year</strong> of age in <strong>MEN2B</strong> mutation.</p>\n<p><strong>Note:</strong> Serum calcium is measured to screen for parathyroid adenoma in MEN 2A.</p><hr><h3>Related Pearl: MEN 2 Syndrome Features</h3><p><strong>MEN 2A</strong></p>\n<ul>\n<li>Known as <strong>Sipple&rsquo;s</strong> syndrome</li>\n<li>Chromosome <strong>10</strong> / <strong>RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Parathyroid adenoma (10&ndash;25%)</li>\n</ul>\n</li>\n</ul>\n<p><strong>MEN 2B</strong></p>\n<ul>\n<li>Known commonly as<strong> MEN 3</strong></li>\n<li>Chromosome<strong> 10/ RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (&gt;90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Other associated abnormalities include: (40&ndash;50%)\n<ul>\n<li>Mucosal neuromas</li>\n<li>Marfanoid habitus</li>\n<li>Medullated corneal nerve fibers</li>\n<li>Megacolon</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a01742751e314b5fb189a29264e911d3x1280x1061.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8822",
      "difficulty": "medium"
    },
    {
      "text": "A patient is diagnosed with medullary thyroid carcinoma. Which of the following could be used to screen the rest of her family?",
      "choices": [
        {
          "id": 1,
          "text": "Pentagastrin"
        },
        {
          "id": 2,
          "text": "Histaminadases"
        },
        {
          "id": 3,
          "text": "Prostaglandin E2 and F2 alpha"
        },
        {
          "id": 4,
          "text": "Serotonin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div class=\"page\" title=\"Page 1577\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Screening of patients with familial MTC was historically done using <strong>pentagastrin stimulation test</strong> for <strong>calcitonin </strong>levels to make the diagnosis.&nbsp;</p>\n<p>Pentagastrin is a synthetic gastrin analogue. It acts on the CCK-B/gastrin receptor of the C cells&nbsp;and <strong>increases</strong> the&nbsp;basal rate of <strong>calcitonin</strong> <strong>secretion</strong>.</p>\n<p>Basal calcitonin level = total C cell mass x rate of secretion.</p>\n<p>Medullary thyroid tumors secrete calcitonin and carcinoembryonic antigen (CEA), but also other peptides such as calcitonin gene-related peptide, histaminadases, prostaglandins E2 and F2&alpha;, and serotonin.</p>\n<p>Another test that can be used for screening is&nbsp;calcium-stimulated calcitonin levels.</p>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: MEN 2 Syndrome Features</h3><p><strong>MEN 2A</strong></p>\n<ul>\n<li>Known as <strong>Sipple&rsquo;s</strong> syndrome</li>\n<li>Chromosome <strong>10</strong> / <strong>RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Parathyroid adenoma (10&ndash;25%)</li>\n</ul>\n</li>\n</ul>\n<p><strong>MEN 2B</strong></p>\n<ul>\n<li>Known commonly as<strong> MEN 3</strong></li>\n<li>Chromosome<strong> 10/ RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (&gt;90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Other associated abnormalities include: (40&ndash;50%)\n<ul>\n<li>Mucosal neuromas</li>\n<li>Marfanoid habitus</li>\n<li>Medullated corneal nerve fibers</li>\n<li>Megacolon</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a01742751e314b5fb189a29264e911d3x1280x1061.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4188",
      "difficulty": "medium"
    },
    {
      "text": "A 32-year-old female was diagnosed with medullary thyroid carcinoma. On USG paratracheal lymph node involvement was found. What is the best method of management of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Total thyroidectomy with central neck dissection"
        },
        {
          "id": 2,
          "text": "Total thyroidectomy with central neck dissection and RAI ablation"
        },
        {
          "id": 3,
          "text": "Total thyroidectomy with  modified radical and central neck dissection"
        },
        {
          "id": 4,
          "text": "Total thyroidectomy with lateral and central neck dissection"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Medullary thyroid carcinoma (MTC) with Level VI or paratracheal lymph node involvement is managed with <strong>total thyroidectomy </strong>with <strong>central neck dissection </strong>and <strong>modified radical neck dissection. </strong></p>\n<p>Surgical management of MTC is as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Extent of cancer</strong></td>\n<td><strong>Surgery done</strong></td>\n</tr>\n<tr>\n<td>\n<p>MTC without LN involvement</p>\n</td>\n<td>Total thyroidectomy + Central neck dissection (prophylactic)</td>\n</tr>\n<tr>\n<td>\n<p><strong>MTC + level VI LN involved</strong></p>\n</td>\n<td><strong>Total thyroidectomy + Central neck dissection (therapeutic) +&nbsp;Modified radical neck dissection (prophylactic)</strong></td>\n</tr>\n<tr>\n<td>\n<p>MTC + other LNs involved</p>\n</td>\n<td>Total thyroidectomy + Central neck dissection + Modified radical neck dissection (therapeutic)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Note:&nbsp;</strong>Prophylactic neck dissection is not routinely performed in papillary or follicular carcinoma.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8820",
      "difficulty": "medium"
    },
    {
      "text": "Prophylactic thyroidectomy is indicated in patients with which of the following features:",
      "choices": [
        {
          "id": 1,
          "text": "Long standing thyroglossal cyst"
        },
        {
          "id": 2,
          "text": "Marfanoid habitus, multiple neuromas on the lip and familial pheochromocytoma,"
        },
        {
          "id": 3,
          "text": "Dense lymphatic infiltration of the thyroid detected on FNAC"
        },
        {
          "id": 4,
          "text": "Upregulation of BRAF"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Prophylactic thyroidectomy is indicated in <strong>MEN 2B</strong> syndrome as they can develop medullary thyroid carcinoma. This syndrome manifests as:</p>\n<ul>\n<li>Pheochromocytoma</li>\n<li>Marfanoid habitus</li>\n<li>Mucosal neuromas</li>\n<li>Medullary thyroid cancer.&nbsp;</li>\n</ul>\n<p>Medullary thyroid carcinoma (MTC) can be inherited as <strong>familial MTC, MEN 2A</strong> or <strong>MEN 2B</strong> syndromes. These conditions are autosomal dominant and occur due to <strong>RET proto-oncogene mutation</strong>. As almost all cases of MEN 2B develop medullary thyroid cancer, a prophylactic thyroidectomy may be performed even during infancy.</p>\n<p>Option A:&nbsp;The most common malignancy in <strong>thyroglossal</strong> cysts is&nbsp;<strong>papillary</strong>&nbsp;thyroid carcinoma. In such a case,&nbsp;Sistrunk operation&nbsp;with&nbsp;total thyroidectomy&nbsp;is considered.</p>\n<p>Option C: <strong>Hashimoto's</strong> thyroiditis shows dense lymphatic infiltration of the thyroid detected on FNAC which is treated with thyroxine. However, total thyroidectomy is performed in malignant transformation to thyroid lymphoma.</p>\n<p>Option D: Upregulation of <strong>BRAF</strong> is associated with <strong>papillary</strong> thyroid carcinoma.</p><hr><h3>Related Pearl: MEN 2 Syndrome Features</h3><p><strong>MEN 2A</strong></p>\n<ul>\n<li>Known as <strong>Sipple&rsquo;s</strong> syndrome</li>\n<li>Chromosome <strong>10</strong> / <strong>RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Parathyroid adenoma (10&ndash;25%)</li>\n</ul>\n</li>\n</ul>\n<p><strong>MEN 2B</strong></p>\n<ul>\n<li>Known commonly as<strong> MEN 3</strong></li>\n<li>Chromosome<strong> 10/ RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (&gt;90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Other associated abnormalities include: (40&ndash;50%)\n<ul>\n<li>Mucosal neuromas</li>\n<li>Marfanoid habitus</li>\n<li>Medullated corneal nerve fibers</li>\n<li>Megacolon</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a01742751e314b5fb189a29264e911d3x1280x1061.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8825",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common site of distant metastasis in patients with medullary thyroid carcinoma?",
      "choices": [
        {
          "id": 1,
          "text": "Liver"
        },
        {
          "id": 2,
          "text": "Bone"
        },
        {
          "id": 3,
          "text": "Lung"
        },
        {
          "id": 4,
          "text": "Adrenal"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Liver</strong> <strong>metastasis</strong> is more common in <strong>medullary</strong> thyroid carcinoma.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of thyroid cancer</strong></td>\n<td><strong>Most common distant site</strong></td>\n</tr>\n<tr>\n<td>Papillary</td>\n<td>Lungs</td>\n</tr>\n<tr>\n<td>Follicular</td>\n<td>Bones</td>\n</tr>\n<tr>\n<td><strong>Medullary</strong></td>\n<td><strong>Liver</strong></td>\n</tr>\n<tr>\n<td>Anaplastic</td>\n<td>Lungs</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8826",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false about the 8th edition AJCC staging of thyroid neoplasms?",
      "choices": [
        {
          "id": 1,
          "text": "In DTC, distant metastasis is IVB"
        },
        {
          "id": 2,
          "text": "In staging, age barrier is 55 years"
        },
        {
          "id": 3,
          "text": "T3a includes minor extrathyroidal extension"
        },
        {
          "id": 4,
          "text": "N1a includes level VI and VII"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Minor extrathyroidal extension</strong> detected only on histological examination is <strong>removed from the definition of T3</strong> disease and therefore has no impact on either T category or overall stage.</p>\n<p><strong>Differentiated Thyroid Cancer:</strong></p>\n<ul>\n<li>The <strong>age</strong> <strong>cutoff</strong> used for staging is increased from 45 to <strong>55 years</strong> of age at diagnosis.&nbsp;</li>\n<li>N1 disease no longer upstages a patient to stage III. If<strong> &lt; 55 years</strong> of age at diagnosis, <strong>N1 disease is stage I</strong>. If <strong>&ge; 55 years</strong> of age, <strong>N1 disease is stage II.</strong></li>\n<li><strong>T3a</strong> is a new category for tumors <strong>&gt; 4 cm confined to the thyroid gland</strong></li>\n<li><strong>T3b</strong> is a new category for tumors of any size demonstrating<strong> gross extrathyroidal extension into strap muscles</strong> (sternohyoid, sternothyroid, thyrohyoid or omohyoid muscles)</li>\n<li><strong>Level VII</strong> lymph nodes, previously classified as lateral neck lymph nodes (N1b) is re-classified as central neck lymph nodes <strong>(N1a)</strong> to be more anatomically consistent and because level VII presented significant coding difficulties for tumor registrars, clinicians and researchers.</li>\n<li>In differentiated thyroid cancer, the presence of <strong>distant metastases</strong> <strong>(M1)</strong> in older patients is classified as <strong>IVB</strong> disease rather than IVC disease. Distant metastasis in anaplastic thyroid cancer continues to be classified as IVC disease.</li>\n</ul>\n<p>Minimal or occult/microcarcinoma are tumors&nbsp;1 cm or less in size. They have&nbsp;no evidence of local invasiveness through the thyroid capsule or angioinvasion. Occult malignancies are&nbsp;usually not associated with lymph node metastases. However, about <strong>25% of patients </strong>with these tumors have associated occult lymph node metastases. These are&nbsp;<strong>nonpalpable </strong>and are found<strong> i</strong><strong>ncidentally</strong>&nbsp;at operative and histologic examinations or at autopsy.&nbsp;&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>TNM staging</td>\n<td>7th AJCC (2010)</td>\n<td><strong>8th AJCC (2018)</strong></td>\n</tr>\n<tr>\n<td>Primary tumor(pT)</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>TX</td>\n<td>Cannot be assessed</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>T0</td>\n<td>No evidence of cancer</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>T1</td>\n<td>Tumour &le; 2 cm, intrathyroidal\n<ul>\n<li>T1a:&nbsp;&le;1 cm, intrathyroidal</li>\n<li>T1b<strong>:</strong>&nbsp;1-2 cm, intrathyroidal</li>\n</ul>\n</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>T2</td>\n<td>\n<div class=\"page\" title=\"Page 927\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>2-4 cm, intrathyroidal</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>T3</td>\n<td>\n<div class=\"page\" title=\"Page 927\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&gt;4 cm limited to the thyroid or any size with minimal extrathyroidal extension (muscle, soft tissue)</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><br />\n<ul>\n<li><strong>T3a:&nbsp;</strong>Tumor <strong>&gt;4 cm limited to the thyroid</strong></li>\n<li><strong>T3b:&nbsp;Gross extrathyroidal extension</strong> invading only <strong>strap muscles</strong> (sternohyoid, sternothyroid, thyrohyoid or omohyoid muscles) from a tumour of any size</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>T4</td>\n<td>\n<div class=\"page\" title=\"Page 927\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>T4a Invades subcutaneous tissue, larynx, trachea, esophagus, or RLN</li>\n<li>T4b Invades prevertebral fascia or encases carotid or mediastinal vessels</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>-do-<br /><br /></p>\n</td>\n</tr>\n<tr>\n<td>Regional lymph nodes (pN)</td>\n</tr>\n<tr>\n<td>NX</td>\n<td>Regional lymph nodes cannot be assessed</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>N0</td>\n<td>No lymph node metastasis</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>N1a</td>\n<td>\n<div class=\"page\" title=\"Page 927\">\n<div class=\"page\" title=\"Page 927\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Positive in level VI; unilateral or bilateral disease</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><strong>Metastasis to level VI or VII;&nbsp;</strong>unilateral or bilateral disease</td>\n</tr>\n<tr>\n<td>N1b</td>\n<td>\n<div class=\"page\" title=\"Page 927\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Metastasis to unilateral, bilateral or contralateral lateral neck lymph nodes (levels I, II, III, IV or V) or retropharyngeal lymph nodes</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>-do-<br /><br /></td>\n</tr>\n<tr>\n<td>Distant metastasis (pM)</td>\n</tr>\n<tr>\n<td>M0</td>\n<td>No Distant metastasis</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>M1</td>\n<td>Distant metastasis present</td>\n<td>-do-</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"3\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; TNM CLASSIFICATION of Thyroid tumours</td>\n</tr>\n<tr>\n<td colspan=\"3\">PAPILLARY OR FOLLICULAR TUMORS</td>\n</tr>\n<tr>\n<td>Stage</td>\n<td>TNM&nbsp;AJCC 7<sup>th</sup> edition</td>\n<td><strong>TNM AJCC 8<sup>th</sup> edition</strong>&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&lt;45 y</td>\n<td>&nbsp;<strong>&lt;55 y</strong></td>\n</tr>\n<tr>\n<td>\n<p>I</p>\n</td>\n<td>&nbsp;Any T, any N, M0</td>\n<td>&nbsp;-do-</td>\n</tr>\n<tr>\n<td>\n<p>II</p>\n</td>\n<td>&nbsp;Any T, any N, M1</td>\n<td>&nbsp;-do-</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;&ge;45 y</td>\n<td><strong>&nbsp;&gt;55 y</strong></td>\n</tr>\n<tr>\n<td>I</td>\n<td>&nbsp;T1, N0, M0</td>\n<td>&nbsp;<strong>T1-2</strong>, N0, M0</td>\n</tr>\n<tr>\n<td>II</td>\n<td>&nbsp;T2, N0, M0</td>\n<td>\n<p>&nbsp;T1-2, <strong>N1</strong>, M0</p>\n<p><strong>T3</strong>, <strong>any N</strong>, M0</p>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td>\n<div class=\"page\" title=\"Page 1572\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>T3, N0, M0</p>\n<p>T1&ndash;3, N1a, M0</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><strong>T4a, any N</strong>, M0</td>\n</tr>\n<tr>\n<td>IV A</td>\n<td>\n<p>T4a, N0-1a, M0</p>\n<p>T1-4a, N1b, M0</p>\n</td>\n<td>&nbsp;<strong>T4b, any N</strong>, M0</td>\n</tr>\n<tr>\n<td>&nbsp;IV B</td>\n<td>&nbsp;T4b, any N, M0</td>\n<td>&nbsp;<strong>any T, any N, M1&nbsp;</strong></td>\n</tr>\n<tr>\n<td>\n<p>IV C</p>\n</td>\n<td>\n<p>Any T, any N, M1</p>\n</td>\n<td>\n<p><strong>- deleted-</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\">MEDULLARY THYROID CANCER&nbsp;</td>\n</tr>\n<tr>\n<td>Stage</td>\n<td>TNM&nbsp;AJCC 7<sup>th</sup> edition</td>\n<td><strong>TNM AJCC 8<sup>th</sup> edition</strong>&nbsp;</td>\n</tr>\n<tr>\n<td>I</td>\n<td>T1, N0, M0</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>II</td>\n<td>T2&ndash;3, N0, M0</td>\n<td>-do- &nbsp;</td>\n</tr>\n<tr>\n<td>III</td>\n<td>T1&ndash;3, N1a, M0</td>\n<td>-do-&nbsp;</td>\n</tr>\n<tr>\n<td>IV A</td>\n<td>\n<p>T4a, any N, M0;</p>\n<p>T1-3, N1b, M0&nbsp;</p>\n</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>IV B</td>\n<td>&nbsp;T4b, any N, M0</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>IV C</td>\n<td>&nbsp;Any T, any N, M1</td>\n<td>-do-</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Anaplastic :</strong></p>\n<ul>\n<li>Unlike previous editions where all anaplastic thyroid cancers were classified as T4 disease, anaplastic cancers now use the<strong> same T&nbsp; definitions as differentiated thyroid cancer</strong>.</li>\n<li><strong>Intrathyroidal disease</strong> (<strong>T1-3a)</strong> is stage <strong>IVA</strong></li>\n<li><strong>Gross extrathyroidal extension</strong>(<strong>T3b,T4)</strong> or <strong>cervical lymph node metastases (N1)</strong> is stage <strong>IVB</strong></li>\n<li><strong>Distant metastases</strong> <strong>(M1)</strong> are stage <strong>IVC</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td colspan=\"3\">\n<p>ANAPLASTIC CANCER</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stage</p>\n</td>\n<td>\n<p>TNM&nbsp;AJCC 7<sup>th</sup> edition</p>\n</td>\n<td>&nbsp;<strong>TNM AJCC 8<sup>th</sup>edition</strong>&nbsp; &nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>IV A</p>\n</td>\n<td>&nbsp;T4a, Any N, M0</td>\n<td>&nbsp;<strong>T1-3a, N0,</strong> M0</td>\n</tr>\n<tr>\n<td>&nbsp;IV B</td>\n<td>&nbsp;T4b, Any N, M0</td>\n<td>\n<p>T1-3a, <strong>N1</strong>, M0;</p>\n<p><strong>T3b</strong>, Any N, M0;</p>\n<p><strong>T4</strong>, Any N, M0</p>\n</td>\n</tr>\n<tr>\n<td>IV C</td>\n<td>&nbsp;Any T, Any N, M1</td>\n<td>&nbsp;-do-</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4711",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following will not be a treatment option for a pregnant patient with papillary thyroid carcinoma?",
      "choices": [
        {
          "id": 1,
          "text": "Total Thyroidectomy"
        },
        {
          "id": 2,
          "text": "Total Thyroidectomy plus Lymph node dissection"
        },
        {
          "id": 3,
          "text": "Radioiodine ablation of thyroid"
        },
        {
          "id": 4,
          "text": "Right Hemithyroidectomy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Radioiodine ablation of thyroid is <strong>contraindicated in pregnant women </strong>due to risk of <strong>radiation exposure to the fetus</strong>.&nbsp;</p>\n<p><strong>Therapeutic uses</strong> for radioactive iodine</p>\n<ul>\n<li><strong>In primary thyrotoxicosis after 45 years.</strong></li>\n<li>In <strong>autonomous toxic nodule after 45 years</strong>, it is useful as remaining gland still will function adequately after radiotherapy.</li>\n<li>In <strong>follicular carcinoma of thyroid, after total thyroidectomy</strong>, if there are secondaries elsewhere in the body, as in bones or lungs, then I<sub>131 </sub>is given.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7589",
      "difficulty": "easy"
    },
    {
      "text": "A patient with papillary thyroid carcinoma underwent total thyroidectomy with central neck dissection, a month ago. At present, a whole-body iodine scan is positive. What is the next step in management?",
      "choices": [
        {
          "id": 1,
          "text": "Re-exploration of thyroid gland"
        },
        {
          "id": 2,
          "text": "Radio-iodine ablation"
        },
        {
          "id": 3,
          "text": "USG-neck"
        },
        {
          "id": 4,
          "text": "Bi-annual follow-up"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Radio-iodine ablation</strong> is undertaken when a whole-body iodine scan is positive after a total thyroidectomy for any differentiated thyroid cancer (papillary or follicular carcinoma).&nbsp;</p>\n<p>The presence of any metastatic or residual thyroid tissue after total thyroidectomy can be detected by observing the uptake of radio-iodine in the entire body. To achieve effective uptake of radio-iodine, TSH levels need to be greatly increased, for example, by withdrawing thyroxine after the surgery for <strong>4-6 weeks</strong>.</p>\n<p>A <strong>positive</strong> whole-body iodine scan after total thyroidectomy indicates that there is either a metastatic or residual disease present. These patients are treated with I<sup>131</sup> for <strong>radio-iodine ablation</strong>.&nbsp;</p>\n<p>A <strong>negative</strong>&nbsp;scan means there is no metastasis or residual thyroid tissue. They are followed up regularly with serum thyroglobulin, TSH and USG-neck.</p>\n<p>If the tumour is <strong>resistant</strong> to radioiodine <strong>ablation</strong>, <strong>EBRT</strong> (external beam radiotherapy) is done.</p><hr><h3>Related Pearl: Radioiodine uptake of thyroid gland</h3><p>Radioactive iodine uptake (RAIU) scans are interpreted as follows:</p>\n<ul>\n<li><strong>High</strong> (or normal) radioiodine uptake indicates de-novo synthesis of the hormone. Therefore, there is increased hormone synthesis</li>\n<li><strong>Low</strong> (nearly absent) radioiodine uptake indicates:\n<ul>\n<li>Inflammation and destruction of thyroid tissue with release of the preformed hormone into the circulation</li>\n<li>Extrathyroidal source of thyroid hormone</li>\n</ul>\n</li>\n</ul>\n<p>Conditions with high and low RAIU are given below:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>High RAIU</strong></td>\n<td><strong>Low RAIU</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Graves&rsquo; disease</li>\n<li>Toxic multinodular goiter</li>\n<li>Toxic adenoma</li>\n<li>Thyroid cancer</li>\n<li>Hydatidiform mole</li>\n<li>TSH-secreting pituitary adenoma</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Acute phase of Hashimoto&rsquo;s thyroiditis</li>\n<li>Drug-induced&mdash; iodine, amiodarone-induced thyroiditis</li>\n<li>Subacute/ Dequervain thyroiditis</li>\n<li>Radiation thyroiditis</li>\n<li>Metastatic follicular thyroid carcinoma</li>\n<li>Factitious (iatrogenic) thyrotoxicosis</li>\n<li>Struma ovarii (extrathyroid source)</li>\n<li>Hamburger thyrotoxicosis (exogenous source)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/84debe461e9e4ef6a8de25fbe9c71e7fx1280x3027.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8815",
      "difficulty": "easy"
    },
    {
      "text": "A whole-body iodine scan is not useful in patients with which thyroid malignancy?",
      "choices": [
        {
          "id": 1,
          "text": "Papillary thyroid cancer"
        },
        {
          "id": 2,
          "text": "Anaplastic thyroid cancer"
        },
        {
          "id": 3,
          "text": "Medullary thyroid cancer"
        },
        {
          "id": 4,
          "text": "Follicular thyroid cancer"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>After a total thyroidectomy, a whole-body iodine scan is not useful for detecting residual thyroid tissue or metastasis in&nbsp;<strong>medullary thyroid carcinoma</strong>.</p>\n<p>Medullary thyroid carcinoma is a tumour of <strong>parafollicular</strong> or<strong> C cells.&nbsp;</strong>These cells which are derived from neural crest cells, <strong>do not take up iodine</strong>. &nbsp;</p>\n<p>A whole-body iodine scan is useful in thyroid&nbsp;tumours derived from follicular cells that take up iodine.</p><hr><h3>Related Pearl: Radioiodine uptake of thyroid gland</h3><p>Radioactive iodine uptake (RAIU) scans are interpreted as follows:</p>\n<ul>\n<li><strong>High</strong> (or normal) radioiodine uptake indicates de-novo synthesis of the hormone. Therefore, there is increased hormone synthesis</li>\n<li><strong>Low</strong> (nearly absent) radioiodine uptake indicates:\n<ul>\n<li>Inflammation and destruction of thyroid tissue with release of the preformed hormone into the circulation</li>\n<li>Extrathyroidal source of thyroid hormone</li>\n</ul>\n</li>\n</ul>\n<p>Conditions with high and low RAIU are given below:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>High RAIU</strong></td>\n<td><strong>Low RAIU</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Graves&rsquo; disease</li>\n<li>Toxic multinodular goiter</li>\n<li>Toxic adenoma</li>\n<li>Thyroid cancer</li>\n<li>Hydatidiform mole</li>\n<li>TSH-secreting pituitary adenoma</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Acute phase of Hashimoto&rsquo;s thyroiditis</li>\n<li>Drug-induced&mdash; iodine, amiodarone-induced thyroiditis</li>\n<li>Subacute/ Dequervain thyroiditis</li>\n<li>Radiation thyroiditis</li>\n<li>Metastatic follicular thyroid carcinoma</li>\n<li>Factitious (iatrogenic) thyrotoxicosis</li>\n<li>Struma ovarii (extrathyroid source)</li>\n<li>Hamburger thyrotoxicosis (exogenous source)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/84debe461e9e4ef6a8de25fbe9c71e7fx1280x3027.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8821",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following scales consider the completeness of surgical resection to determine the prognosis of a patient with thyroid cancer?",
      "choices": [
        {
          "id": 1,
          "text": "AMES"
        },
        {
          "id": 2,
          "text": "AGES"
        },
        {
          "id": 3,
          "text": "MACIS"
        },
        {
          "id": 4,
          "text": "TNM"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>MACIS scale includes completeness of the original surgical resection to determine the prognosis of the thyroid cancer.</p>\n<p><strong>Prognostic indicators</strong> of well differentiated thyroid cancers:&nbsp;</p>\n<ul>\n<li class=\"li1\"><strong>AGES</strong> system - <strong>A</strong>ge, histologic<strong> G</strong>rade, <strong>E</strong>xtrathyroidal invasion, and metastases and tumor <strong>S</strong>ize.</li>\n<li class=\"li1\"><strong>AMES</strong> system - <strong>A</strong>ge (men &lt;40 years old, women &lt;50 years old), <strong>M</strong>etastases, <strong>E</strong>xtrathyroidal spread, and <strong>S</strong>ize of tumors (&lt; or &gt;5 cm).\n<ul>\n<li class=\"li1\">DAMES - DNA aneuploidy + AMES</li>\n<li class=\"li1\">GAMES - Grade + AMES</li>\n</ul>\n</li>\n<li class=\"li1\"><strong>TNM</strong> staging - <strong>T</strong>umor, <strong>N</strong>odal status,<strong> M</strong>etastases.</li>\n<li class=\"li1\"><strong>MACIS</strong> scale (postop modification) - distant <strong>M</strong>etastases, <strong>A</strong>ge at presentation (&lt;40 or &gt;40 years old), <strong>Completeness of original surgical resection</strong>, extrathyroidal <strong>I</strong>nvasion, and <strong>S</strong>ize of original lesion (in centimeters).</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4672",
      "difficulty": "easy"
    }
  ]
}